To evaluate the effect of indigenous and imported low molecular weight heparin (LMWH) in the treatment of chronic hepatitis and hepatic cirrhosis aiming at seeking a safe and effective anti-fibrosis therapy.
[Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
Institute of Liver Disease, Hangzhou Sixth People's Hospital, Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, Zhejiang, China.
